CA9 and lung cancer: Previous studies have demonstrated that CA IX-directed immunoliposomal docetaxel exhibited the strongest growth inhibitory effect against CA IX-positive lung cancer cells when compared with non-targeted liposomal docetaxel or free docetaxel solution [118].